Old Web
English
Sign In
Acemap
>
authorDetail
>
Susan P. Wood
Susan P. Wood
Pfizer
Rheumatoid arthritis
Tofacitinib
Medicine
Physical therapy
Janus kinase inhibitor
4
Papers
339
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Analysis of Infections and All‐Cause Mortality in Phase II, Phase III, and Long‐Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis
2014
Arthritis & Rheumatism
Stanley N. Cohen
Sebastião Cezar Radominski
Juan J. Gomez-Reino
Lisy Wang
Sriram Krishnaswami
Susan P. Wood
Koshika Soma
Chudi I. Nduaka
Kenneth Kwok
Hernan Valdez
B. Benda
Richard Riese
Show All
Source
Cite
Save
Citations (111)
Safety and Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, for the Treatment of Rheumatoid Arthritis in Open-label, Longterm Extension Studies
2014
The Journal of Rheumatology
J. Wollenhaupt
Joel Silverfield
Eun-Bong Lee
Jeffrey R. Curtis
Susan P. Wood
Koshika Soma
Chudy I. Nduaka
B. Benda
David Gruben
Hiroyuki Nakamura
Yoshihiro Komuro
Samuel H. Zwillich
Lisy Wang
Richard Riese
Show All
Source
Cite
Save
Citations (220)
analysis of Early Neutropenia, Clinical Response, and Serious Infection Events in Patients Receiving Tofacitinib for Rheumatoid Arthritis. : 2489
2014
Arthritis & Rheumatism
Vibeke Strand
A. Dikranian
J. Beal
Kenneth Kwok
Sriram Krishnaswami
Susan P. Wood
Chudy I. Nduaka
Show All
Source
Cite
Save
Citations (0)
THU0136 Cardiovascular safety findings in rheumatoid arthritis patients treated with tofacitinib (CP-690,550), a novel, oral jak inhibitor
2013
Annals of the Rheumatic Diseases
Christina Charles-Schoeman
P. Wicker
U. Sechtem
Miguel A. González-Gay
Susan P. Wood
M. Boy
Jamie Geier
David Gruben
Koshika Soma
R. Riese
J. Bradley
Show All
Source
Cite
Save
Citations (8)
1